Digital Biomarkers最新文献

{"title":"Digital Measures That Matter to Patients: A Framework to Guide the Selection and Development of Digital Measures of Health.","authors":"Christine Manta,&nbsp;Bray Patrick-Lake,&nbsp;Jennifer C Goldsack","doi":"10.1159/000509725","DOIUrl":"https://doi.org/10.1159/000509725","url":null,"abstract":"<p><strong>Background: </strong>With the rise of connected sensor technologies, there are seemingly endless possibilities for new ways to measure health. These technologies offer researchers and clinicians opportunities to go beyond brief snapshots of data captured by traditional in-clinic assessments, to redefine health and disease. Given the myriad opportunities for measurement, how do research or clinical teams know what they <i>should</i> be measuring? Patient engagement, early and often, is paramount to thoughtfully selecting what is most important. Regulators encourage stakeholders to have a patient focus but actionable steps for continuous engagement are not well defined. Without patient-focused measurement, stakeholders risk entrenching digital versions of poor traditional assessments and proliferating low-value tools that are ineffective, burdensome, and reduce both quality and efficiency in clinical care and research.</p><p><strong>Summary: </strong>This article synthesizes and defines a sequential framework of core principles for selecting and developing measurements in research and clinical care that are meaningful for patients. We propose next steps to drive forward the science of high-quality patient engagement in support of measures of health that matter in the era of digital medicine.</p><p><strong>Key messages: </strong>All measures of health should be meaningful, regardless of the product's regulatory classification, type of measure, or context of use. To evaluate meaningfulness of signals derived from digital sensors, the following four-level framework is useful: Meaningful Aspect of Health, Concept of Interest, Outcome to be measured, and Endpoint (exclusive to research). Incorporating patient input is a dynamic process that requires more than a single, transactional touch point but rather should be conducted continuously throughout the measurement selection process. We recommend that developers, clinicians, and researchers reevaluate processes for more continuous patient engagement in the development, deployment, and interpretation of digital measures of health.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"4 3","pages":"69-77"},"PeriodicalIF":0.0,"publicationDate":"2020-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000509725","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38511099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Device- and Analytics-Agnostic Infrastructure for Continuous Inpatient Monitoring: A Technical Note.","authors":"Noé Brasier,&nbsp;Lukas Geissmann,&nbsp;Miro Käch,&nbsp;Markus Mutke,&nbsp;Bianca Hoelz,&nbsp;Fiorangelo De Ieso,&nbsp;Jens Eckstein","doi":"10.1159/000509279","DOIUrl":"https://doi.org/10.1159/000509279","url":null,"abstract":"<p><p>The internet of healthcare things aims at connecting biosensors, clinical information systems and electronic health dossiers. The resulting data expands traditionally available diagnostics with digital biomarkers. In this technical note, we report the implementation and pilot operation of a device- and analytics-agnostic automated monitoring platform for in-house patients at hospitals. Any available sensor, as well as any analytics tool can be integrated if the application programming interface is made available. The platform consists of a network of Bluetooth gateways communicating via the hospital's secure Wi-Fi network, a server application (Device Hub) and associated databases. Already existing access points or low-cost hardware can be used to run the gateway software. The platform can be extended to a remote patient monitoring solution to close the gap between in-house treatments and follow-up patient monitoring.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"4 2","pages":"62-68"},"PeriodicalIF":0.0,"publicationDate":"2020-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000509279","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38511517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Book Review","authors":"R. Kapur","doi":"10.1159/000508200","DOIUrl":"https://doi.org/10.1159/000508200","url":null,"abstract":"","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"4 1","pages":"60 - 61"},"PeriodicalIF":0.0,"publicationDate":"2020-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000508200","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48081621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials.","authors":"Frank Kramer,&nbsp;Javed Butler,&nbsp;Sanjiv J Shah,&nbsp;Christian Jung,&nbsp;Savina Nodari,&nbsp;Stephan Rosenkranz,&nbsp;Michele Senni,&nbsp;Luke Bamber,&nbsp;Stephan Cichos,&nbsp;Chrysanthi Dori,&nbsp;Toeresin Karakoyun,&nbsp;Gabriele Jenny Köhler,&nbsp;Kinjal Patel,&nbsp;Paolo Piraino,&nbsp;Thomas Viethen,&nbsp;Praneeth Chennuru,&nbsp;Ayse Paydar,&nbsp;Jason Sims,&nbsp;Richard Clark,&nbsp;Rob van Lummel,&nbsp;Alexandra Müller,&nbsp;Chad Gwaltney,&nbsp;Salko Smajlovic,&nbsp;Hans-Dirk Düngen,&nbsp;Wilfried Dinh","doi":"10.1159/000507696","DOIUrl":"https://doi.org/10.1159/000507696","url":null,"abstract":"<p><strong>Aims: </strong>Heart failure (HF) affects approximately 26 million people worldwide. With an aging global population, innovative approaches to HF evaluation and management are needed to cope with the worsening HF epidemic. The aim of the Real-Life Multimarker Monitoring in Patients with Heart Failure (REALIsM-HF) study (NCT03507439) is to evaluate a composite instrument comprising remote, real-time, activity-monitoring devices combined with daily electronic patient-reported outcome (ePRO) items in patients who have been hospitalized for HF and are undergoing standard HF assessment (e.g., 6-min walking distance [6MWD], blood biomarkers, Kansas City Cardiomyopathy Questionnaire [KCCQ], and echocardiography).</p><p><strong>Methods: </strong>REALIsM-HF is an ongoing, 12-week, observational study enrolling 80-100 patients aged ≥45 years with HF with preserved ejection fraction (HFpEF; EF ≥45%) or reduced EF (HFrEF; EF ≤35%). Statistical analyses will include examining the association between data from wearables (the AVIVO^© mobile patient management patch or VitalPatch^© biosensor, and the DynaPort MoveMonitor^©), daily ePROs, and conventional HF metrics (e.g., serum/plasma biomarkers, 6MWD, KCCQ, and echocardiographic parameters). The feasibility of and patient compliance with at-home devices will be documented, and the data captured for the purpose of establishing reference values in patients with HFpEF or HFrEF will be summarized.</p><p><strong>Conclusions: </strong>The REALIsM-HF study is to evaluate the longitudinal daily activity profiles of patients with HF and correlate these with changes in serum/plasma biomarker profiles, symptoms, quality of life, and cardiac function and morphology to inform the use of wearable activity monitors for developing novel therapies and managing patients.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"4 2","pages":"45-59"},"PeriodicalIF":0.0,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000507696","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38511097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing Smartphone-Based Objective Assessments of Physical Function in Rheumatoid Arthritis Patients: The PARADE Study.","authors":"Valentin Hamy,&nbsp;Luis Garcia-Gancedo,&nbsp;Andrew Pollard,&nbsp;Anniek Myatt,&nbsp;Jingshu Liu,&nbsp;Andrew Howland,&nbsp;Philip Beineke,&nbsp;Emilia Quattrocchi,&nbsp;Rachel Williams,&nbsp;Michelle Crouthamel","doi":"10.1159/000506860","DOIUrl":"https://doi.org/10.1159/000506860","url":null,"abstract":"<p><strong>Background: </strong>Digital biomarkers that measure physical activity and mobility are of great interest in the assessment of chronic diseases such as rheumatoid arthritis, as it provides insights on patients' quality of life that can be reliably compared across a whole population.</p><p><strong>Objective: </strong>To investigate the feasibility of analyzing iPhone sensor data collected remotely by means of a mobile software application in order to derive meaningful information on functional ability in rheumatoid arthritis patients.</p><p><strong>Methods: </strong>Two objective, active tasks were made available to the study participants: a wrist joint motion test and a walk test, both performed remotely and without any medical supervision. During these tasks, gyroscope and accelerometer time-series data were captured. Processing schemes were developed using machine learning techniques such as logistic regression as well as explicitly programmed algorithms to assess data quality in both tasks. Motion-specific features including wrist joint range of motion (ROM) in flexion-extension (for the wrist motion test) and gait parameters (for the walk test) were extracted from high quality data and compared with subjective pain and mobility parameters, separately captured via the application.</p><p><strong>Results: </strong>Out of 646 wrist joint motion samples collected, 289 (45%) were high quality. Data collected for the walk test included 2,583 samples (through 867 executions of the test) from which 651 (25%) were high quality. Further analysis of high-quality data highlighted links between reduced mobility and increased symptom severity. ANOVA testing showed statistically significant differences in wrist joint ROM between groups with light-moderate (220 participants) versus severe (36 participants) wrist pain (<i>p</i> < 0.001) as well as in average step times between groups with slight versus moderate problems walking about (<i>p</i> < 0.03).</p><p><strong>Conclusion: </strong>These findings demonstrate the potential to capture and quantify meaningful objective clinical information remotely using iPhone sensors and represent an early step towards the development of patient-centric digital endpoints for clinical trials in rheumatoid arthritis.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":" ","pages":"26-43"},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000506860","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38023748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Need for Artificial Intelligence in Digital Therapeutics.","authors":"Adam Palanica,&nbsp;Michael J Docktor,&nbsp;Michael Lieberman,&nbsp;Yan Fossat","doi":"10.1159/000506861","DOIUrl":"https://doi.org/10.1159/000506861","url":null,"abstract":"<p><p>Digital therapeutics is a newly described concept in healthcare which is proposed to change patient behavior and treat medical conditions using a variety of digital technologies. However, the term is rarely defined with criteria that make it distinct from simply <i>digitized</i>versions of traditional <i>therapeutics</i>. Our objective is to describe a more valuable characteristic of digital therapeutics, which is distinct from traditional medicine or therapy: that is, the utilization of artificial intelligence and machine learning systems to monitor and predict individual patient symptom data in an adaptive clinical feedback loop via digital biomarkers to provide a precision medicine approach to healthcare. Artificial intelligence platforms can learn and predict effective interventions for individuals using a multitude of personal variables to provide a customized and more tailored therapy regimen. Digital therapeutics coupled with artificial intelligence and machine learning also allows more effective clinical observations and management at the population level for various health conditions and cohorts. This vital differentiation of digital therapeutics compared to other forms of therapeutics enables a more personalized form of healthcare that actively adapts to patients' individual clinical needs, goals, and lifestyles. Importantly, these characteristics are what needs to be emphasized to patients, physicians, and policy makers to advance the entire field of digital healthcare.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":" ","pages":"21-25"},"PeriodicalIF":0.0,"publicationDate":"2020-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000506861","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37927085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Continuous Digital Assessment for Weight Loss Surgery Patients.","authors":"Ernesto Ramirez,&nbsp;Nikki Marinsek,&nbsp;Benjamin Bradshaw,&nbsp;Robert Kanard,&nbsp;Luca Foschini","doi":"10.1159/000506417","DOIUrl":"https://doi.org/10.1159/000506417","url":null,"abstract":"<p><p>We conducted a survey about recent surgical procedures on a large connected population and requested each individual's permission to access data from commercial wearable devices they may have been wearing around the time of the procedure. For subcohorts of 66-118 patients who reported having a weight loss procedure and who had dense Fitbit data around their procedure date, we examined several daily measures of behavior and physiology in the 12 weeks leading up to and the 12 weeks following their procedures. We found that the weeks following weight loss operations were associated with fewer daily total steps, smaller proportions of the day spent walking, lower resting and 95th percentile heart rates, more total sleep time, and greater sleep efficiency. We demonstrate that consumer-grade activity trackers can capture behavioral and physiological changes resulting from weight loss surgery and these devices have the potential to be used to develop measures of patients' postoperative recovery that are convenient, sensitive, scalable, individualized, and continuous.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":" ","pages":"13-20"},"PeriodicalIF":0.0,"publicationDate":"2020-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000506417","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37927084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Translation of Digital Health Technologies to Advance Precision Medicine: Informing Regulatory Science.","authors":"Joan E Adamo,&nbsp;Robert V Bienvenu Ii,&nbsp;Felipe Dolz,&nbsp;Michael Liebman,&nbsp;Wendy Nilsen,&nbsp;Scott J Steele","doi":"10.1159/000505289","DOIUrl":"https://doi.org/10.1159/000505289","url":null,"abstract":"<p><p>The proliferation of digital technologies and the application of sophisticated data analysis techniques are increasingly viewed as having the potential to transform translational research and precision medicine. While digital technologies are rapidly applied in innovative ways to develop new diagnostics and therapies, the ultimate approval and adoption of these emerging methods presents several scientific and regulatory challenges. To better understand and address these regulatory science gaps, a working group of the Clinical and Translational Science Awards Program convened the Regulatory Science to Advance Precision Medicine Forum focused on digital health, particularly examining gaps in the use, validation, and interpretation of data from sensors that collect and tools that analyze digital biomarkers. The key findings and recommendations provided here emerged from the Forum and include the need to enhance areas related to data standards, data quality and validity, knowledge management, and building trust between all stakeholders.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"4 1","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000505289","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9349509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Usability of a Wrist-Worn Smartwatch in a Direct-to-Participant Randomized Pragmatic Clinical Trial.","authors":"Michael Galarnyk, Giorgio Quer, Kathryn McLaughlin, Lauren Ariniello, Steven R Steinhubl","doi":"10.1159/000504838","DOIUrl":"10.1159/000504838","url":null,"abstract":"<p><strong>Background: </strong>The availability of a wide range of innovative wearable sensor technologies today allows for the ability to capture and collect potentially important health-related data in ways not previously possible. These sensors can be adopted in digitalized clinical trials, i.e., clinical trials conducted outside the clinic to capture data about study participants in their day-to-day life. However, having participants activate, charge, and wear the digital sensors for long hours may prove to be a significant obstacle to the success of these trials.</p><p><strong>Objective: </strong>This study explores a broad question of wrist-wearable sensor effectiveness in terms of data collection as well as data that are analyzable per individual. The individuals who had already consented to be part of an asymptomatic atrial fibrillation screening trial were directly sent a wrist-wearable activity and heart rate tracker device to be activated and used in a home-based setting.</p><p><strong>Methods: </strong>A total of 230 participants with a median age of 71 years were asked to wear the wristband as frequently as possible, night and day, for at least a 4-month monitoring period, especially to track heart rhythm during sleep.</p><p><strong>Results: </strong>Of the individuals who received the device, 43% never transmitted any data. Those who used the device wore it a median of ∼15 weeks (IQR 2-24) and for 5.3 days (IQR 3.2-6.5) per week. For rhythm detection purposes, only 5.6% of all recorded data from individuals were analyzable (with beat-to-beat intervals reported).</p><p><strong>Conclusions: </strong>This study provides some important learnings. It showed that in an older population, despite initial enthusiasm to receive a consumer-quality wrist-based fitness device, a large proportion of individuals never activated the device. However, it also found that for a majority of participants it was possible to successfully collect wearable sensor data without clinical oversight inside a home environment, and that once used, ongoing wear time was high. This suggests that a critical barrier to overcome when incorporating a wearable device into clinical research is making its initiation of use as easy as possible for the participant.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"3 3","pages":"176-184"},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011723/pdf/dib-0003-0176.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37675813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Continuous Sound Collection Using Smartphones and Machine Learning to Measure Cough.","authors":"Lucia Kvapilova,&nbsp;Vladimir Boza,&nbsp;Peter Dubec,&nbsp;Martin Majernik,&nbsp;Jan Bogar,&nbsp;Jamileh Jamison,&nbsp;Jennifer C Goldsack,&nbsp;Duncan J Kimmel,&nbsp;Daniel R Karlin","doi":"10.1159/000504666","DOIUrl":"https://doi.org/10.1159/000504666","url":null,"abstract":"<p><strong>Background: </strong>Despite the efforts of research groups to develop and implement at least partial automation, cough counting remains impractical. Analysis of 24-h cough frequency is an established regulatory endpoint which, if addressed in an automated manner, has the potential to ease cough symptom evaluation over multiple 24-h periods in a patient-centric way, supporting the development of novel treatments for chronic cough, an unmet clinical need.</p><p><strong>Objectives: </strong>In light of recent technological advancements, we propose a system based on the use of smartphones for objective continuous sound collection, suitable for automated cough detection and analysis. Two capabilities were identified as necessary for naturalistic cough assessment: (1) recording sound in a continuous manner (sound collection), and (2) detection of coughs from the recorded sound (cough detection).</p><p><strong>Methods: </strong>This work did not involve any human subject testing or trials. For sound collection, we designed, built, and verified technical parameters of a smartphone application for sound collection. Our cough detection work describes the development of a mathematical model for sound analysis and cough identification. Performance of the model was compared to previously published results of commercially available solutions and to human raters. The compared solutions use the following methods to automatically or semi-automatically assess cough: 24-h sound recording with an ambulatory device with multiple microphones, automatic silence removal, and manual recording review for cough count.</p><p><strong>Results: </strong>Sound collection: the application demonstrated the ability to continuously record sounds using the phone's internal microphone; the technical verification informed the configuration of the technical and user experience parameters. Cough detection: our cough recognition sensitivity to cough as determined by human listeners was 90 at 99.5% specificity preset and 75 at 99.9% specificity preset for a dataset created from publicly available data.</p><p><strong>Conclusions: </strong>Sound collection: the application reliably collects sound data and uploads them securely to a remote server for subsequent analysis; the developed sound data collection application is a critical first step toward future incorporation in clinical trials. Cough detection: initial experiments with cough detection techniques yielded encouraging results for application to patient-collected data from future studies.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"3 3","pages":"166-175"},"PeriodicalIF":0.0,"publicationDate":"2019-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000504666","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37675811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}